Hilma

Hilma develops natural remedies supported by scientific research, focusing on digestive health, sleep support, and overall wellness. Their products are tailored for individuals seeking effective, natural alternatives to traditional treatments. Hilma was founded in 2020 in Brooklyn, US, by Hilary Quartner, Lily Galef, and Nina Mullen. The company specializes in creating health products based on scientific research.

As of November 2022, Biocodex acquired a majority stake in Hilma to enhance its US market presence. The CEO is Nurudeen Ajayi. Hilma specializes in natural remedies formulated from scientific research and clinical data. Their product line includes solutions for digestive health, sleep support, and overall wellness.

Key offerings are the Digestive Health Hub and the Daily Pre + Probiotic, designed for consumers looking for holistic health strategies without synthetic ingredients, primarily marketed through direct-to-consumer e-commerce in North America. Hilma generates revenue through direct-to-consumer sales on its online platform. Products are priced between USD 17 and USD 30, appealing to a diverse clientele interested in natural health solutions. Revenue primarily comes from individual sales, often enhanced by promotional offers, with flagship items like the Daily Pre + Probiotic driving significant sales.

Following the November 2022 acquisition by Biocodex, Hilma plans to leverage this partnership to expand its product offerings and increase its market reach. The acquisition supports Biocodex's strategy for international growth and aims to solidify Hilma's presence in the US. Future product launches are anticipated as part of this growth strategy.